Belinostat‐induced upregulation of Bim protein expression has also been reported in leukemia [37] and lymphoma cell lines [38], as well as in models of lung carcinoma [39], while the induction of Noxa protein in response to this HDAC inhibitor has been described in a lymphoma cell line [40]. The gene discussed is BCL2L11; the disease is leukemia.